CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • TNDM Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Tandem Diabetes Care (TNDM)

Company Profile
Tandem Diabetes Care, Inc. is a medical device company dedicated to improving the lives of people with diabetes through relentless innovation and revolutionary customer experience. The Company takes an innovative, user-centric approach to the design, development and commercialization of products for people with diabetes who use insulin. Tandem's flagship product, the t:slim X2™ insulin pump, is capable of remote software updates using a personal computer and features integrated continuous glucose monitoring. Tandem is based in San Diego, California.
Tandem Diabetes Care logo

Company profile

Ticker
TNDM
Exchange
NASDAQ
Website
www.tandemdiabetes.com
CEO
John Sheridan
Employees
Incorporated
Delaware
Location
California
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Haemonetics • Hill-Rom • Nuvasive ...
SEC CIK
0001438133
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
Tandem Diabetes Care Canada, Inc. • Sugarmate Inc. ...
IRS number
204327508

TNDM stock data

Analyst ratings and price targets

Last 3 months
Current price
Average target
$55.00
Low target
$43.00
High target
$70.00
Wells Fargo
Upgraded
Equal-Weight
$43.00
15 Nov 22
Raymond James
Maintains
Outperform
$52.00
4 Nov 22
Piper Sandler
Maintains
Overweight
$70.00
3 Nov 22
Latest filings (excl ownership)
View all
8-K
Tandem Diabetes Care Completes Acquisition of Insulin Patch Pump Developer, AMF Medical
23 Jan 23
8-K
Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
10 Jan 23
8-K
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical
13 Dec 22
10-Q
2022 Q3
Quarterly report
2 Nov 22
8-K
Tandem Diabetes Care Announces Third Quarter 2022 Financial Results
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
8-K
Tandem Diabetes Care Announces Second Quarter 2022 Financial Results
3 Aug 22
8-K
Tandem Diabetes Care Welcomes Two New Members to Board of Directors
16 Jun 22
8-K
Submission of Matters to a Vote of Security Holders
27 May 22
SD
Conflict minerals disclosure
27 May 22
Transcripts
View all
TNDM
Earnings call transcript
2022 Q3
3 Nov 22
TNDM
Earnings call transcript
2022 Q2
4 Aug 22
TNDM
Earnings call transcript
2022 Q1
4 May 22
TNDM
Earnings call transcript
2021 Q4
23 Feb 22
TNDM
Earnings call transcript
2021 Q3
4 Nov 21
TNDM
Earnings call transcript
2021 Q2
5 Aug 21
TNDM
Earnings call transcript
2021 Q1
6 May 21
TNDM
Earnings call transcript
2020 Q4
25 Feb 21
TNDM
Earnings call transcript
2020 Q3
5 Nov 20
TNDM
Earnings call transcript
2020 Q2
31 Jul 20
Latest ownership filings
View all
SC 13G
BlackRock Inc.
24 Jan 23
4
Rajwant Sodhi
6 Jan 23
4
DAVID B BERGER
19 Dec 22
4
Rick Carpenter
19 Dec 22
4
Leigh Vosseller
30 Nov 22
4
John F Sheridan
30 Nov 22
4
Susan Morrison
30 Nov 22
4
James Leal
30 Nov 22
4
BRIAN B HANSEN
30 Nov 22
4
Elizabeth Anne Gasser
30 Nov 22

Financial summary

Financial statements Chart TNDM financial data
Quarter (USD) Sep 22 Jun 22 Mar 22 Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 123.79 mm 123.79 mm 123.79 mm 123.79 mm 123.79 mm 123.79 mm
Cash burn (monthly) (no burn) (no burn) 15.83 mm 5.35 mm (no burn) (no burn)
Cash used (since last report) n/a n/a 63.68 mm 21.50 mm n/a n/a
Cash remaining n/a n/a 60.11 mm 102.29 mm n/a n/a
Runway (months of cash) n/a n/a 3.8 19.1 n/a n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

TNDM institutional ownership history Ownership history
13F holders Current Prev Q Change
Total holders 302 335 -9.9%
Opened positions 39 37 +5.4%
Closed positions 72 84 -14.3%
Increased positions 102 149 -31.5%
Reduced positions 117 108 +8.3%
13F shares Current Prev Q Change
Total value 3.07 bn 3.78 bn -18.8%
Total shares 69.01 mm 69.49 mm -0.7%
Total puts 394.01 k 190.60 k +106.7%
Total calls 322.00 k 622.90 k -48.3%
Total put/call ratio 1.2 0.3 +299.9%
Largest owners Shares Value Change
FMR 8.97 mm $429.37 mm +38.8%
Vanguard 6.19 mm $296.40 mm -2.8%
BLK Blackrock 6.09 mm $291.56 mm -4.0%
Capital World Investors 4.56 mm $217.99 mm +59.5%
Corrib Capital Management 4.50 mm $13.14 mm 0.0%
Champlain Investment Partners 3.12 mm $149.48 mm +18.3%
Alger Associates 2.69 mm $117.15 mm 0.0%
Brown Capital Management 2.01 mm $96.19 mm +18.8%
Eminence Capital 1.59 mm $76.12 mm NEW
BLVGF Bellevue 1.57 mm $74.93 mm +19.0%
Largest transactions Shares Bought/sold Change
FMR 8.97 mm +2.51 mm +38.8%
STT State Street 0.00 -1.72 mm EXIT
Capital World Investors 4.56 mm +1.70 mm +59.5%
Eminence Capital 1.59 mm +1.59 mm NEW
Alliancebernstein 92.48 k -1.26 mm -93.2%
IVZ Invesco 1.23 mm -933.83 k -43.1%
RTW Investments 322.00 k -600.63 k -65.1%
Eagle Asset Management 520.78 k +520.78 k NEW
Champlain Investment Partners 3.12 mm +484.31 k +18.3%
FHI Federated Hermes 663.34 k -477.77 k -41.9%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

TNDM insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
4 Jan 23 Rajwant Sodhi Common Stock Option exercise Acquire M No No 0 1,069 0.00 2,873
4 Jan 23 Rajwant Sodhi RSU Common Stock Option exercise Acquire M No No 0 1,069 0.00 1,070
16 Dec 22 David B Berger Common Stock Sell Dispose S No No 40.25 10,000 402.50 k 3,029
16 Dec 22 David B Berger Common Stock Option exercise Acquire M No No 18.86 10,000 188.60 k 13,029
16 Dec 22 David B Berger Stock Option Common Stock Option exercise Acquire M No No 18.86 10,000 188.60 k 10,000
15 Dec 22 Rick Carpenter Common Stock Payment of exercise Dispose F No No 40.42 562 22.72 k 1,395
15 Dec 22 Rick Carpenter Common Stock Option exercise Acquire M No No 0 1,624 0.00 1,957
15 Dec 22 Rick Carpenter RSU Common Stock Option exercise Acquire M No No 0 1,624 0.00 4,871
15 Dec 22 David B Berger Common Stock Sell Dispose S No No 40.32 15,000 604.80 k 3,029
15 Dec 22 David B Berger Common Stock Option exercise Acquire M No No 18.86 15,000 282.90 k 18,029
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
26 Jan 23
Wolfe Research Initiates Coverage On Tandem Diabetes Care with Peer Perform Rating
26 Jan 23
Wolfe Research analyst Mike Polark initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Peer Perform rating.
CommVault Systems, Halozyme Therapeutics And Other Big Stocks Moving Lower On Wednesday
11 Jan 23
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Wednesday. Here are some big stocks recording losses in today’s session.
Tandem Diabetes Acquires Swiss Based Insulin Patch Pump Developer
13 Dec 22
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical; Includes Previous Investment Of CHF 8M, Cash Payment Of CHF 26.4M Due At Closing, Additional Contingent Payments Of Up To CHF 129.6M
13 Dec 22

Press releases

From Benzinga Pro
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2022 Financial Results on February 22, 2023
19 Jan 23
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2022 results after the financial markets close on Wednesday,
Tandem Diabetes Care Reports Preliminary, Unaudited 2022 Sales and Reaffirms 2023 Outlook
10 Jan 23
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a global insulin delivery and diabetes technology company, today reported its preliminary, unaudited sales for the fourth quarter and year ended December 31, 2022 and worldwide
Tandem Diabetes Care to Present at the 41st Annual J.P. Morgan Healthcare Conference
3 Jan 23
Tandem Diabetes Care, Inc. (NASDAQ:TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the 41st Annual J.P. Morgan Healthcare Conference on
Tandem Diabetes Care to Acquire Insulin Patch Pump Developer, AMF Medical
13 Dec 22
Tandem Diabetes Care Earns Great Place to Work Certification™
16 Nov 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn